Gene86
ACTL6A: actin like 6A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ACTL6A: actin like 6A. Genes, record 86. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/86
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O96019 | Actin-like protein 6A | 429 | 25 | Ensembl, GeneID, HGNC |
Source UniProt
Patents25
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 12854 | O96019 | Espacenet |
| JP 2025164846 A | 2025-10-30 | 24 | O96019 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 12854 | O96019 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 1553 | O96019 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 1553 | O96019 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 104524 | O96019 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 163 | O96019 | Espacenet |
| WO 2021132592 A | 2021-07-01 | 74 | O96019 | Espacenet |
| US 9878056 B2 | 2018-01-30 | 906 | O96019 | Espacenet |
| JP 2017141230 A | 2017-08-17 | 4974 | O96019 | Espacenet |
NIH grants989
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ACTL6A papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 12 | 2025 |
| R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 10 | 2025 |
| R01CA163915 | ATP-Dependent Chromatin Remodeling in Human Malignancy | 9 | 2025 |
| R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 9 | 2025 |
| ZIAES071006 | Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 4 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
Source NIH's project files
Papers989
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overexpression of ACTL6A is associated with poor prognosis in gastric cancer, and nuclear level is an independent predictor. | Transl Cancer Res | 2026 | 42180885 | PubTator, text mining | PubMed |
| p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials. | Cell Death Discov | 2026 | 41876478 | PubTator, text mining | PubMed |
| Recognition and remodelling of nucleosomes and hexasomes by the human INO80 complex. | Nucleic Acids Res | 2026 | 41775336 | PubTator, text mining | PubMed |
| PROTAC-based protein degradation: a window of opportunity for melanoma therapy. | J Biomed Sci | 2026 | 41761284 | PubTator, text mining | PubMed |
| Actin-related protein 6 regulates the Hedgehog signaling pathway: Molecular basis for stemness maintenance of hepatoma cells. | Cytojournal | 2026 | 41743751 | PubTator, text mining | PubMed |
| TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes. | J Biomed Sci | 2026 | 41742188 | PubTator, text mining | PubMed |
| WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis. | Front Cell Dev Biol | 2026 | 41727322 | PubTator, text mining | PubMed |
| SWI/SNF Chromatin Remodelling Complex in Hepatic Physiology: Mechanistic Insights Into Development, Homeostasis and Pathogenesis. | J Cell Mol Med | 2026 | 41578412 | PubTator, text mining | PubMed |
| Dated gene duplications elucidate the evolutionary assembly of eukaryotes. | Nature | 2026 | 41339551 | PubTator, text mining | PubMed |
| ACTL6A accelerates the progression of NSCLC through hippo/YAP signaling axis and TAMs-mediated immune regulation. | Int Immunopharmacol | 2026 | 41223612 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/86
GET https://conductscience.org/api/genes/v1/86/patents?page=2